BIOCODEX IN NORDICS Biocodex committed to healthcare with passion and conviction. BIOCODEX IN NORDICS Our Products Microbiota Health Our gut is home to more than 100 trillion microorganisms. The balance of these bacteria is vital for our gut health, but also for our immunity, mental and physical health Women and Family Health Biocodex and Laboratoires IPRAD have products in the field of women and family health. Laboratories have developed and marketed medicinal, healthcare and wellness products designed to improve everyday life. Prescription Medicines Biocodex is selling and marketing numerous partners’ prescription products in therapeutic areas like dermatology, oncology, or neurology. We educate Health Care Professionals and Pharmacists broadly and offer support for many patient groups. All Our Products What's new at Biocodex BIOCODEX MICROBIOTA FOUNDATION SUPPORTS NON-PROFIT RESEARCH PROJECTS Biocodex Microbiota Foundation Biocodex Microbiota Foundation promotes research on microbiota and their interactions with various human pathologies and runs national and international calls for « non-profit » research projects awarding selected projects. Visit our microbiota fundation website SOCIAL RESPONSIBILITY The Missing page helps girls understand their bodies In 2019, we launched a campaign encouraging French schools to provide more comprehensive information on the female anatomy to help girls understand and take care of their bodies. Visit "The Missing page" HEALTHCARE PROFESSIONALS Biocodex Microbiota Hard Talks Biocodex partners with WGO to offer series of webinars where experts from around the world discuss different human gut microbiota topics. Access Microbiota Hard Talks Our heritage Biocodex is a family-owned company founded more than 60 years ago to market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Biocodex has since expanded its expertise in gut microbiota, evolving from French pioneer to an international player in the microbiota realm. Our heritage Growing while remaining agile by capitalizing on our values. NICOLAS COUDURIER Chief Executive Officer at BIOCODEX 1530 employees worldwide € 387 M In Revenue 2020 20 subsidiaries 114 Distribution partners Our development Terms of use Data Privacy Cookies preferences Sitemap Contact Follow Us Copyright © 2021 Biocodex

Urologie Biocodex » Nos produits » Autres produits » LOGIFLOX® LOGIFLOX® Loméfloxacine Chlorhydrate DCI : Loméfloxacine Chlorydrate Dosage : 400 mg, comprimé sécable Classe : Antibiotique urinaire RCP LOGIFLOX NOTICE LOGIFLOX Conditions d’utilisation Protection des données Préférences cookies Plan du site Contact Dialogue prescripteurs de santé Suivez-nous Copyright © 2021 Biocodex X We use cookies to ensure the smooth operation of our website, optimize the user experience and improve our services. Some features are based on services offered by third parties and require your prior consent. OK, accept all Decline all Personalize